15 Jan2015
Australian clinical research company expands operation in Hong Kong
Hong Kong (HKSAR) – Sydney-based Novotech today (January 15) announced that it has expanded its Hong Kong operation into a permanent office with more staff to meet the increasing demand in the pharmaceutical market for clinical research.